Composti policiclici

6-Methoxyindole-2-carboxylic acid methyl ester is a pyrroloquinoline alkaloid with cytotoxic and antiproliferative activities. It inhibits the growth of cancer cells in culture by inducing apoptosis and cell cycle arrest. 6-Methoxyindole-2-carboxylic acid methyl ester has been shown to be effective against breast cancer cell lines in vitro and to inhibit the proliferation of breast cancer cells in vivo. This compound also inhibits the growth of a number of other cancer cell lines such as prostate, colon, lung, liver, stomach, and leukemia. The mechanism of action for this compound is thought to be due to its ability to act as an intramolecular quencher of reactive oxygen species (ROS) or as an inhibitor of DNA synthesis through inhibition of ribonucleotide reductase activity.

4-Aminoindole is a heterocycle with a carboxy group and four nitrogen atoms. It can be synthesized by reacting hydrochloric acid with nitrobenzene. 4-Aminoindole has shown potential as a drug target, which may be due to its ability to inhibit the enzyme carboxamidase. The compound is also acidic in water, making it an ideal candidate for use as an acid catalyst. Electropolymerization of 4-aminoindole has been achieved using Pt electrodes in the presence of an acidic environment. This reaction results in the formation of functional groups on the metal surface that are not found in most other electropolymerization reactions.

4,6-Dimethoxyindole is a molecule that can be used as an amide or chloride. The molecular modeling study indicated that the 4,6-dimethoxyindole is hydrophobic and has a molecular weight of 164.4 g/mol. In the acetylation reaction, the 4,6-dimethoxyindole was synthesized with an acetyl group on one side of the molecule and an acetate group on the other side of the molecule. This molecule has shown to have anticholinesterase activity in vitro and can be used as an antibiotic. The synthesis of this molecule was confirmed by X-ray diffraction analysis, which showed that it had a crystal structure with two molecules in space group P2(1)2(1).

6-Chloro-7-iodo-7-deazapurine is a nucleoside analogue that is synthesized by a cross-coupling reaction between 6-chloro-2,4(1H,3H)-pyrimidinedione and 7-iodo-7-(trifluoromethyl)purine. 6CIDP has been shown to inhibit growth of epidermal cells at concentrations as low as 0.1 µM, with cytostatic effects seen at 10 µM. 6CIDP has also been shown to potently inhibit the replication of the human papilloma virus in vitro and in vivo. 6CIDP is currently being investigated for the treatment of AIDS and other viral infections. The molecular modeling studies on this compound have revealed that it may be a potent inhibitor of the epidermal growth factor receptor (EGFR).

1-Benzyl-3-hydroxy-1H-indazole is a hydrophilic matrix that can be used to deliver drugs. The hydrophilicity of the matrix allows it to dissolve in water and form a paste when mixed with water. The drug or drug formulation is dispersed within the paste and delivered to the site of action by the matrix. 1-Benzyl-3-hydroxy-1H-indazole has shown inhibition of inflammation, which may be due to its ability to inhibit prostaglandin synthesis. 1BHI can also be used for electroreduction reactions, such as reduction of metal ions, at temperatures ranging from -10°C to +20°C.

6-Trifluoromethylindole is a carbamic acid that can be synthesized with the help of a sulfoxides. Carbamic acid reacts with an aryl halide to form an unsymmetrical biaryl. 6-Trifluoromethylindole has been shown to act as a modulator in Friedel-Crafts reactions, which may be used for the synthesis of heterocycles. This chemical has also been shown to react with alkyl chlorides and sulfonium salts to form carbamic acids and sulfoxides, respectively.

2,6-Dichloro-3-deazapurine is an isomer of the nucleoside guanosine. It has been shown to inhibit the synthesis of viruses in cell cultures and may be useful in the treatment of leukemia. The synthesis of 2,6-dichloro-3-deazapurine can be achieved through a solid-phase synthesis that uses synthons as starting materials. The molecular modelling studies have shown that this molecule has a potential to bind to adenosine receptor subtypes A2a, A2b, and A3.

6-Chloropurine is an isothiouronium salt that is metabolized by the enzyme thiopurine methyltransferase to its active form, 6-methylthioinosine. It has been shown to inhibit the growth of bacterial cells in culture by binding to their adenine nucleotide. 6-Chloropurine inhibits the synthesis of purines and pyrimidines, which are involved in DNA replication and RNA synthesis. 6-Chloropurine has been shown to have cytotoxic effects on certain human carcinoma cell lines and may be used as a chemotherapeutic agent for these types of cancer. The drug has also been shown to have high values with aerobacter aerogenes, which is a bacterium that can cause lung infections.

1-Phenanthrol is a naturally occurring phenanthrene derivative that is used in the treatment of cervical cancer. It has been shown to be effective in the chemiluminescence method using urine samples, which indicates that it may have an effect on the body's metabolism. 1-Phenanthrol has also been shown to inhibit the production of s-phenylmercapturic acid, which is a metabolite of aromatic amines. This inhibition may be due to its receptor binding properties as it binds to and activates the peroxisome proliferator-activated receptor alpha (PPARα) and PPARγ. 1-Phenanthrol also inhibits angiotensin II type 1 receptors and can cause vasorelaxation by reducing blood pressure.